LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a market capitalization of $559 million, recently revealed retrospective outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback